Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
708
-
Total 13F shares, excl. options
-
232,446,713
-
Shares change
-
-18,482,127
-
Total reported value, excl. options
-
$9,681,481,087
-
Value change
-
-$828,806,005
-
Put/Call ratio
-
98.63%
-
Number of buys
-
329
-
Number of sells
-
-291
-
Price
-
$41.65
Significant Holders of GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) as of Q2 2015
806 filings reported holding GSK - GLAXOSMITHKLINE PLC - SPONSORED ADR as of Q2 2015.
GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) has 708 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 232,446,713 shares
.
Largest 10 shareholders include Dodge & Cox (12,476,998 shares), ROYAL BANK OF CANADA (11,643,210 shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (11,615,471 shares), Fisher Asset Management, LLC (11,533,371 shares), WELLS FARGO & COMPANY/MN (11,222,072 shares), FMR LLC (10,975,769 shares), STATE STREET CORP (10,497,901 shares), JPMORGAN CHASE & CO (9,237,629 shares), FEDERATED INVESTORS INC /PA/ (7,016,676 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (6,225,873 shares).
This table shows the top 708 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.